Post-stroke Haptic Feedback Use Deficit: A Comparative and Reliability Study (NCT06344221) | Clinical Trial Compass
UnknownNot Applicable
Post-stroke Haptic Feedback Use Deficit: A Comparative and Reliability Study
90 participantsStarted 2024-04-15
Plain-language summary
The aim of this comparative and reliability study is to highlight a deficit in the use of vibrotactile sensory feedback (haptic effect) in the planning and execution of fine manual dexterity movements after stroke. The investigators will include 3 groups of subjects, 1 group of young healthy subjects, 1 of older subjects matched in age and sex to the group of chronic stroke patients. Participants will take part in clinical tests of fine motor skills and sensitivity and will use a device to assess the key components of manual dexterity, to which vibrotactile sensors will be added. If they so wish, participants will be able to take part in a transcranial magnetic stimulation (TMS) study to assess the facilitation of cortical excitability due to the haptic effect.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria for healthy controls:
* between 18 and 40 years old
* or age and sex match with chronic stroke patients
* Ability to perform motor, cognitive (MOCA score ≥26/30) and sensory assessment
Inclusion Criteria for chronic stroke patients:
* More than 18 years old
* Ability to perform motor, cognitive (MOCA score ≥26/30) and sensory assessment
* First symptomatic stroke more than 6 months ago
* Upper limb paresis (≤4/5 on the MRC scale)
* Feel ≥3/6 touch on the index and thumb fingers
* Box and Blocks test score between 1 and 54 blocks / min
Exclusion Criteria:
* Contraindication to TMS (epilepsy, metal implants)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Assessing haptic effect during a dexterity exercise with and without sensory feedback: finger independence